Veterans Affairs Ann Arbor Healthcare System — Ann Arbor, Michigan

Veterans Affairs Ann Arbor Healthcare System is a clinical research site located in Ann Arbor, Michigan, United States 48109.

Crixeo Clinical Trials Trust Score: 89/100 (GOOD). This profile has not yet been claimed by the site owner.

Veterans Affairs Ann Arbor Healthcare System has participated in 6 clinical trials with 2 currently active.

Therapeutic areas: Liver Metastases, Non-small Cell Lung Cancer, Small Cell Lung Cancer (SCLC).

Sponsors: VA Ann Arbor Healthcare System, Boehringer Ingelheim, Genentech, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Ann Arbor

Browse all research sites in Michigan · View every site in Ann Arbor

Sponsor Feasibility Report

Trust Score: 89/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Veterans Affairs Ann Arbor Healthcare System?

Veterans Affairs Ann Arbor Healthcare System has a Crixeo Trust Score of 89/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Veterans Affairs Ann Arbor Healthcare System conducted?

Veterans Affairs Ann Arbor Healthcare System has 6 clinical trials on record, with 2 currently active. Their work covers Liver Metastases, Non-small Cell Lung Cancer, Small Cell Lung Cancer (SCLC).

Is Veterans Affairs Ann Arbor Healthcare System accredited by Crixeo Clinical Trials?

Veterans Affairs Ann Arbor Healthcare System has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Veterans Affairs Ann Arbor Healthcare System?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.